Patrick Jamieson

Patrick Jamieson currently serves as Vice President of Strategy & Special Projects at Alloy Therapeutics, Inc. since October 2024. Prior to this role, Patrick held the position of Vice President of Transformation at Ginkgo Bioworks, Inc. from November 2022 to October 2024 and Vice President of Strategy & Corporate Development at Motional from December 2019 to November 2022. Patrick has also contributed as a Board Observer for KRONO-SAFE, otonomo, and Affectiva between January 2019 and March 2020. Previous experience includes serving as Director of Strategic Investments at Aptiv, Director and Associate Director of Business Development & Licensing at GSK, and Manager of Business Development & Licensing at Novartis Consumer Health. Early in the career, Patrick was a Segment Finance Manager and Finance Associate at Thermo Fisher Scientific. Educational background includes a Bachelor of Science in Economics-Finance from Bentley University and Copenhagen Business School, and participation in executive education programs at MIT Sloan in 2015 and 2023.